TITLE

The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease

AUTHOR(S)
Freel, E. Marie; Connell, John M. C.
PUB. DATE
March 2006
SOURCE
Current Hypertension Reviews;2006, Vol. 2 Issue 1, p21
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aldosterone is a key cardiovascular hormone. Recent studies have illustrated its role in cardiac fibrosis and left ventricular hypertrophy as well as in impaired vascular reactivity. Moreover, many of these actions have been shown to be independent of its known effects on blood pressure. In a clinical setting, the benefits of aldosterone blockade in cardiovascular disease have been adequately demonstrated in recent large, randomised clinical trials. Aldosterone blockade was once limited by dose-related side effects, however, the introduction of a new, more selective, aldosterone receptor antagonist (eplerenone) has led to an increase in its use as a therapeutic strategy in cardiovascular disease. The role of aldosterone in hypertension has also been recently re-evaluated. As a result more widespread screening of hypertensive subjects using the aldosterone to renin ratio (ARR), the prevalence of Primary Aldosteronism (PA) is now estimated, albeit controversially, to be at least 10%. It is now accepted that screening for PA should be more widespread and not limited to those with hypokalaemia. Moreover, whilst there remains debate over the exact labelling of individuals with hypertension and raised ARR it is clear that such subjects have aldosterone levels inappropriate for the prevailing renin ('aldosterone-associated hypertension'). It is important that such individuals are identified since they can be offered more targeted treatment with selective aldosterone blockade or even surgery to control or normalise blood pressure.
ACCESSION #
19533138

 

Related Articles

  • Primary Hyperaldosteronism in the Hypertensive Disease. Fardella, Carlos E.; Carvajal, Cristian A.; Mosso, Lorena M. // Current Hypertension Reviews;2006, Vol. 2 Issue 1, p33 

    Primary aldosteronism (PA) is one of the potentially curable forms of hypertension. The hypertension is secondary to aldosterone action in the kidney, reabsorbing sodium and water that increases the intravascular volume and blood pressure. PA was previously believed to account for less than 1%...

  • Aldosterone synthase inhibitors in hypertension: current status and future possibilities. Hargovan, Milan; Ferro, Albert // JRSM Cardiovascular Disease;Jan-Dec2014, Vol. 3, p1 

    The renin-angiotensin aldosterone system is a critical mechanism for controlling blood pressure, and exerts most of its physiological effects through the action of angiotensin II. In addition to increasing blood pressure by increasing vascular resistance, angiotensin II also stimulates...

  • Comparative surveillance of two major categories of AHDS among selected area of Indore district. Sumeet, Dwivedi; Tripti, Mishra; Patel, Ritesh // Journal of Pharmacy Research;Dec2009, Vol. 2 Issue 12, p1848 

    The present paper through the light on the marketing survey of anti-hypertensive drugs and a comparative surveillance of two major categories of AHDs having less drug-drug interaction and adverse drug reaction which benefits the patient's compliance towards the use of drugs in hypertension....

  • Factors Related to Poor Control of Hypertension in the Hypertension Clinic. Kadir, Shaharuddin Che; Mohamed, Mohd Sapawi; Yusof, Zurkurnai // International Medical Journal;Mar2009, Vol. 16 Issue 1, p19 

    Objective: A study was conducted at the hypertension clinic, Hospital Universiti Sains Malaysia to assess the proportion of patients who achieved their blood pressure targets and to determine the factors associated with uncontrolled hypertension. Design: A cross-sectional study. Materials and...

  • The renin-aldosterone system during normal and hypertensive pregnancy. Elsheikh, A.; Creatsas, G.; Mastorakos, G.; Milingos, S.; Loutradis, D.; Michalas, S. // Archives of Gynecology & Obstetrics;Jan2001, Vol. 264 Issue 4, p182 

    Gestational hypertension complicates approximately 5%–7% of pregnancies and it may be deleterious to both maternal and fetal health. Gestational hypertension is a multisystem disorder which always resolves itself after delivery; its primary pathology still remains incompletely clarified....

  • Using Plasma Renin (PRA) Testing to Design Follow-Up Drug Treatment Strategies in Hypertensive Patients Already Taking Antirenin System Drugs. Sealey, Jean E.; Laragh, John H. // American Journal of Hypertension;Sep2009, Vol. 22 Issue 9, p950 

    The article presents a commentary on the study about using plasma renin (PRA) testing to design drug treatment strategies in hypertensive patients. According to the authors, the information provided by the test can be used to determine whether the patient is more likely to respond to a...

  • Drug Therapy for the Secondary Prevention of Stroke in Hypertensive Patients: Current Issues and Options. Lüders, Stephan // Drugs;2007, Vol. 67 Issue 7, p955 

    Hypertension is the major risk factor for ischaemic and haemorrhagic clinical strokes as well as for silent brain infarcts with a continuous association between both systolic and diastolic blood pressures. Epidemiological data highlight the increasing burden to come over the next decades. ...

  • A Note on the Measurement of Hypertension in HHANES. Geronimus, Arline T.; Neidert, Lisa J.; Bound, John // American Journal of Public Health;Dec1990, Vol. 80 Issue 12, p1437 

    Using data from the HHANES, we found the rates of elevated blood pressure readings on clinical examination to be extremely low for a sample of Mexican American and Puerto Rican women. The prevalence rates were one-fourth to one-fifth the rates found for a comparable sample of White women from...

  • Spice up the hypertension diet--curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension.  // Nutrition & Metabolism;2011, Vol. 8 Issue 1, p72 

    The article focuses on the study conducted to examine the effects of black pepper compounds and curcuma on increased blood pressure and remodeling of aorta in the rat model of experimental L-NAME induced hypertension. It mentions the increase of blood pressure that is caused by L-NAME was...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics